Am J Transplant, Volume 22, Suppl 3 Archives - Page 180 of 190 - ATC Abstracts

2022 American Transplant Congress
Cold Pulsatile Perfusion Resistance of Deceased Donor Kidneys Mainly Dependent on Renal Mass, Donor Age and Donor AKI, Other Donor Factors Have Minimal Impact
D. Keith, E. Lessmann
Kidney Transplant, Sacred Heart Hospital, Pensacola, FL
*Purpose: To determine the factors influencing resistance to flow during cold pulsatile perfusion preservation (CPPP) of deceased donor kidneys.*Methods: All donor kidneys procured for possible…
2022 American Transplant Congress
A Dose Dependent Effect of Varying Tacrolimus Concentrations on Cytomegalovirus Viral Specific T Cell Interferon Gamma Expression
H. L. Kleiboeker¹, M. R. Jorgenson¹, R. O. Meyers², O. Ganz², S. Parajuli³, J. Galipeau⁴
¹Pharmacy, University of Wisconsin Hospital and Clinics, Madison, WI, ²Program for Advanced Cell Therapy, University of Wisconsin Hospital and Clinics and School of Medicine and Public Health, Madison, WI, ³Medicine, Division of Nephrology, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴Medicine, Division of Hematology and Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: Tacrolimus, considered the backbone of transplant immunosuppression, is associated with increased risk of viral infections, including cytomegalovirus (CMV), due to its potent inhibitory effect…
2022 American Transplant Congress
Living Related Kidney Donation for Alternative Complement Pathway Diseases: Long-Term Outcomes
Y. Caliskan¹, S. Safak², A. B. Dirim², A. Velioglu³, B. Yelken⁴, O. A. Oto², A. Yildiz⁵, N. Garayeva², H. Yazici², A. Ersoy⁵, A. Turkmen⁴, K. L. Lentine¹
¹Saint Louis University, Saint Louis, MO, ²Istanbul University, Istanbul, Turkey, ³Marmara University, Istanbul, Turkey, ⁴Koc University Hospital, Istanbul, Turkey, ⁵Uludag University, Bursa, Turkey
*Purpose: Atypical hemolytic-uremic syndrome (aHUS) and C3 glomerulopathy (C3G) are rare conditions that cause severe kidney disease. Data to guide the evaluation of living related…
2022 American Transplant Congress
The Role of Advanced Practice Providers in Liver Transplant Centers
S. Nargiso, L. Sher, V. Tristan
Keck Medical Center at University of Southern California, Los Angeles, CA
*Purpose: Care for the liver transplant (LT) recipient requires expertise and consistency. Due to the rotation of trainees and the emphasis on surgical experience for…
2022 American Transplant Congress
Efficacy and Safety of PCSK-9 Inhibitor, Evolocumab for Lipid Management in Kidney Transplant Recipients
J. Pandav¹, R. Saranu¹, S. Muhsin¹, N. Murakami¹, S. Gabardi¹, K. Safa², A. Chandraker¹
¹Renal division, Brigham and Women's Hospital, Boston, MA, ²Renal division, Massachusetts General Hospital, Boston, MA
*Purpose: Dyslipidemia is common in kidney transplant recipients (KTRs). KDIGO guidelines suggest all KTRs should be treated with statins due to the high risk of…
2022 American Transplant Congress
Deceased Donor Kidney Transplantation from Donors with Acute Kidney Injury: Realities and Costs
S. Iskhagi¹, R. Shahbazov¹, A. Ball¹, S. Loerzel¹, E. Shaban², B. Gallay², R. Hod Dvorai³, J. Leggat², M. Hanlon¹, R. Saidi¹
¹Department of Surgery, Division of Transplantation, SUNY Upstate Medical University, Syracuse, NY, ²Department of Medicine, Division of Nephrology, SUNY Upstate Medical University, Syracuse, NY, ³Department of Pathology and Laboratory Medicine, SUNY Upstate Medical University, Syracuse, NY
*Purpose: The use of kidneys from deceased donors with acute kidney injury (AKI) is one of the options to expand donor pool. Several studied have…
2022 American Transplant Congress
Early Outcomes of Kidney Transplant Recipients from Donors with Severe Sars-cov-2 Pneumonia
M. Rosenzweig, M. Finotti, A. Gupta, S. Lee, N. Onaca, G. J. McKenna, J. Bayer, H. Fernandez, R. Ruiz, E. Martinez, A. Yango, T. Sam, C. Spak, B. Fischbach, G. Testa, A. Wall
Baylor University Medical Center, Dallas, TX
*Purpose: Transplantation of kidneys from donors with active SARS-CoV-2 infection is uncommon due to concerns about the risk of viral transmission and kidney quality. To…
2022 American Transplant Congress
Diabetes Mellitus and Blood Glucose Variability Increases the 30-day Readmission Rate After Kidney Transplantation
H. Chakkera¹, C. Cook¹, S. Saghafian², A. Orfanoudaki³
¹Mayo Clinic Arizona, Scottsdale, AZ, ²Harvard University, Boston, MA, ³University of Oxford, Oxford, United Kingdom
*Purpose: The 30-day readmission rate is a surrogate metric of quality of care and mortality after kidney transplantation. Diabetes and observations of glucose variability during…
2022 American Transplant Congress
Defining the Characteristics and Graft Outcomes of Kidney Transplant Recipients with Pre-Transplant Elevated Plasma Oxalate Levels
D. Khan, N. Zhang, M. Keddis
Mayo Clinic, Scottsdale, AZ
*Purpose: The objective of this study is to compare graft outcomes for patients with pre-transplant elevated plasma oxalate (Pox) compared to a matched cohort.*Methods: Kidney…
2022 American Transplant Congress
A Large-Scale National Cohort Study Assessing the Impact of Diabetes and Obesity on Kidney Transplant Outcomes
V. Rohan¹, M. Casey¹, S. Zemin², P. Baliga², D. Taber²
¹Surgery, Medical University of South Carolina, Charleston, SC, ²Medical University of South Carolina, Charleston, SC
*Purpose: Type 2 Diabetes Mellitus (T2DM) is the most common cause of renal failure in patients undergoing kidney transplantation (KT) and highly correlated with obesity.…